Naringenin
CAS 480-41-1
Naringenin (CAS 480-41-1) is a pharmaceutical compound with 9 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | IC50 | 60641.96347826087 nM | 67 | - |
| - | Potency | 28852.63888888889 nM | 17 | - |
| - | EC50 | 26136.666666666668 nM | 15 | - |
| - | Ki | 6482.111 nM | 10 | - |
| - | MIC | 204 ug.mL-1 | 4 | - |
| - | Kd | 14817.205 nM | 3 | - |
| - | AC50 | 4051.7400000000002 nM | 3 | - |
| - | IC50 | 50 ug.mL-1 | 3 | - |
| - | EC50 | 9.47 ug.mL-1 | 1 | - |
IUPHAR Ligand-Target Data
Curated ligand-target interaction rows with action, affinity, and literature identifiers.
| Target | Action | Affinity | PubMed |
|---|---|---|---|
| TAS2R39 TAS2R39 |
Agonist | 4.480000019073486 pEC50 | 24117141 |
| TRPM3 TRPM3 |
Channel blocker | 5.199999809265137 pIC50 | 23190005|24006495 |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Naringenin used for in pharmaceutical contexts?
Naringenin (CAS 480-41-1) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Naringenin?
No adverse-event association or SIDER side-effect rows are rendered for Naringenin in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Naringenin also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for NARINGENIN with EU status "permitted".
What clinical phase is Naringenin in?
No phase 1-4 clinical development badge is rendered for Naringenin because the matched compound identifier rows do not contain a max-phase value.